Friday, March 4, 2022

< + > Antibody-Activated Endothelial Cells Increase the Risk of Blood Clots with Covid-19

Antiphospholipid antibodies activity may help explain hypercoagulation associated with late stages of Covid-19 and long-haul disease. Blood samples from nearly 250 individuals hospitalized for Covid-19 found that these “rouge” antibodies activate endothelial cells, risking widespread blood clots.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > What's behind EHR-induced clinician burnout? And how to solve it?

When evaluating electronic health record systems to minimize documentation burden, usability is always the big challenge, says one informati...